Welcome to Bioquark Inc.
Bioquark Inc. is focused on the development of novel biologics that have the ability to alter the regulatory state of human tissues and organs, with the goal of curing a range of chronic diseases, as well as effecting complex regeneration.
The biologic regulatory states of our cells, tissues and organs represent the central control processes behind our health (as well as our unfortunate transition towards disease, degeneration and aging).
Merging 21st century knowledge of regenerative biology, evolutionary medicine, and complex systems, Bioquark’s core program focuses on developing a novel class of substances termed combinatorial biologics, which take a unique approach to reversing underlying disease, degeneration or aging processes, as opposed to only effecting the symptoms of such conditions.
Combinatorial biologics are modeled off of biochemical dynamics found in various species which can naturally modify biologic regulatory state to achieve beneficial endpoints such as complex tissue and organ regeneration, disease reversion, and even biological age reversal.
Bioquark’s lead candidate in our biologic portfolio is known as BQ-A. Read more about BQ-A.